| Judy Carol Smith, MS, CCC-SLP | |
|
910 Wallace Ave, Leitchfield, KY 42754-2414 | |
| (270) 259-1657 | |
| Not Available |
| Full Name | Judy Carol Smith |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 910 Wallace Ave, Leitchfield, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285858456 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1993 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Judy Carol Smith, MS, CCC-SLP 312 Hendricks St, Leitchfield, KY 42754-2112 Ph: (270) 259-1657 | Judy Carol Smith, MS, CCC-SLP 910 Wallace Ave, Leitchfield, KY 42754-2414 Ph: (270) 259-1657 |
News Archive
Exposure to low levels of mercury in utero increases a child's risk for developing attention deficit/hyperactivity disorder, report researchers.
Scientists have found that sleep helps consolidate memories, fixing them in the brain so we can retrieve them later. Now, new research is showing that sleep also seems to reorganize memories, picking out the emotional details and reconfiguring the memories to help you produce new and creative ideas, according to the authors of an article in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
Researchers at the University of Manchester, UK, aimed to systematically review the literature to provide evidence on SARS-CoV-2 and audio-vestibular symptoms. They found that COVID-19 has been tied to hearing loss, vertigo, and tinnitus.
Nuclear engineers at Oregon State University have developed a small, portable and inexpensive radiation detection device that should help people all over the world better understand the radiation around them, its type and intensity, and whether or not it poses a health risk.
ACT Biotech Inc., a privately held biotechnology company developing a portfolio of oral kinase inhibitors as anti-cancer drugs, today announced the acceptance of the Investigational New Drug (IND) application for ACTB1003 by the US Food and Drug Administration (FDA). The company has now assembled a complete preclinical package, including manufacturing and toxicology studies, allowing ACTB1003 to enter a clinical trial.
› Verified 4 days ago
Kayla Diane Kittinger, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 635 S Main St Ste B, Leitchfield, KY 42754 Phone: 270-287-0656 Fax: 270-230-0328 | |
Larissa Haynes, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 635 S Main St Ste B, Leitchfield, KY 42754 Phone: 270-287-0656 Fax: 270-230-0328 | |
Catrina Davis Pickerell, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 635 S Main St Ste B, Leitchfield, KY 42754 Phone: 270-287-0656 | |
Amber Elizabeth Whobrey, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 635 S Main St # B, Leitchfield, KY 42754 Phone: 270-287-0656 | |
Sarah Ward, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 910 Wallace Ave, Leitchfield, KY 42754 Phone: 270-259-9469 | |
Mrs. Andrea Leigh Kemp, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 70 Roark Rd, Leitchfield, KY 42754 Phone: 270-230-7479 Fax: 270-230-1260 |